Differential deletions in 3p are associated with the development of head and neck squamous cell carcinoma in Indian patients

被引:17
作者
Chakraborty, SB
Dasgupta, S
Roy, A
Sengupta, A
Ray, B
Roychoudhury, S
Panda, CK
机构
[1] Chittaranjan Natl Canc Inst, Dept Oncogene Regulat, Kolkata 700026, W Bengal, India
[2] Bankura Sammilani Med Coll, Dept Pathol, Bankura, W Bengal, India
[3] Canc Ctr & Welfare Home, Kolkata, W Bengal, India
[4] Indian Stat Inst, Anthropol & Human Genet Unit, Kolkata 700035, W Bengal, India
[5] Indian Inst Chem Biol, Dept Human Genet & Gen, Kolkata 700032, W Bengal, India
关键词
D O I
10.1016/S0165-4608(03)00127-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study we performed detailed deletion mapping of two broad regions in the short arm (p) of chromosome 3 (i.e., 3p21.2similar top22 and 3p12similar top13), which were shown to have a high rate of deletions in head and neck lesions in our previous study. Using 18 highly polymorphic microsatellite markers, the deletion mapping was done in 35 dysplastic lesions and 46 primary head and neck squamous cell carcinoma (HNSCC) samples from Indian patients. Within the 21.6-megabase (Mb) region of 3p21.1similar top21.33, we have identified four areas (D1, 3p21.33; D2, 3p21.32; D3, 3p21.31; D4, 3p21.1) that showed a high frequency (46%-69%) of deletions in our samples. In the 3p12similar top13 region, we narrowed down the deletion within the 0.7-Mb region (D5, 3p12.1). Among these five regions (D1-D5), deletion in D3 is suggested to be necessary for the development of early dysplastic lesions, whereas the deletion in D2 may be necessary for dysplastic lesions and tumor progression. On the other hand, the deletion in D5 is significantly associated with progression of the lesions from mild/moderate to severe dysplasia. The deletions in D I and D4, however, are required for tumor progression. As in our previous study, microsatellite size alterations (MA) were observed to be high in and around the highly deleted regions and gradually increased during the progression of the tumor. Loss of normal copy/interstitial alterations of chromosome 3 in the late stages of the tumor as well as rare biallelic alterations around the highly deleted regions also were seen in our samples. Human papilloma virus infection has been found to be associated with the deletion in the D5 region and MA in the D1 region, whereas nodal involvement of the tumor correlated only with the MA in D1 and D5. Thus, this study indicates that multiple tumor suppressor genes whose differential deletions are associated with the development of HNSCC may be present in 3p. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:130 / 138
页数:9
相关论文
共 36 条
[1]  
ADAMSON R, 1994, ONCOGENE, V9, P2077
[2]   HUMAN PAPILLOMAVIRUSES IN 91 ORAL CANCERS FROM INDIAN BETEL QUID CHEWERS - HIGH PREVALENCE AND MULTIPLICITY OF INFECTIONS [J].
BALARAM, P ;
NALINAKUMARI, KR ;
ABRAHAM, E ;
BALAN, A ;
HAREENDRAN, NK ;
BERNARD, HU ;
CHAN, SY .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (04) :450-454
[3]  
Califano J, 1996, CANCER RES, V56, P2488
[4]   Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India [J].
D'Costa, J ;
Saranath, D ;
Dedhia, P ;
Sanghvi, V ;
Mehta, AR .
ORAL ONCOLOGY, 1998, 34 (05) :413-420
[5]  
Daigo Y, 1999, CANCER RES, V59, P1966
[6]   Mapping of the candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of an Indian patient population [J].
Dasgupta, S ;
Mukherjee, N ;
Roy, S ;
Roy, A ;
Sengupta, A ;
Roychowdhury, S ;
Panda, CK .
ORAL ONCOLOGY, 2002, 38 (01) :6-15
[7]  
DEMETRICK DJ, 1993, GENOMICS, V1, P144
[8]   The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis [J].
Dreijerink, K ;
Braga, E ;
Kuzmin, I ;
Geil, L ;
Duh, FM ;
Angeloni, D ;
Zbar, B ;
Lerman, MI ;
Stanbridge, EJ ;
Minna, JD ;
Protopopov, A ;
Li, JF ;
Kashuba, V ;
Klein, G ;
Zabarovsky, ER .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) :7504-7509
[9]  
ELNAGGAR AK, 1995, CANCER RES, V55, P2656
[10]  
FIELD JK, 1994, INT J ONCOL, V4, P543